Ceruloplasmin functional changes in Parkinson's disease-cerebrospinal fluid

Area of Science:

• Neuroscience
• Biochemistry

Background:

• Ceruloplasmin is a CSF ferroxidase crucial for iron homeostasis and oxidative damage protection.
• Reduced ceruloplasmin activity in Parkinson's disease (PD) is linked to iron accumulation.
• Previous work showed ceruloplasmin oxidation and deamidation of NGR-motifs, enhancing integrin binding.

Purpose of the Study:

• To investigate if NGR-motif deamidation and gain of integrin-binding function accompany the loss of ceruloplasmin ferroxidase activity in PD patient CSF.

Main Methods:

• Analysis of endogenous ceruloplasmin in CSF from PD patients.
• In vitro experiments using exogenous ceruloplasmin exposed to pathological CSF environments.
• Detection of hydrogen peroxide levels in CSF.

Main Results:

• PD patient CSF contains ceruloplasmin with deamidated (962)NGR-motifs, altered structure, and gained integrin-binding function.
• Abnormal hydrogen peroxide levels in PD CSF drive these ceruloplasmin modifications.
• Pathological CSF induced similar changes in exogenous ceruloplasmin, reducing ferroxidase activity and adding integrin-binding properties.

Conclusions:

• In PD, ceruloplasmin in CSF loses ferroxidase function and gains integrin-binding function due to oxidative stress.
• This altered ceruloplasmin may trigger signaling pathways in CNS cells, impacting PD pathogenesis.
• The pro-oxidant CSF environment in PD may limit the efficacy of ceruloplasmin-based therapeutic approaches in humans.